To hear about similar clinical trials, please enter your email below
Trial Title:
An Observational Study Based on Endometrial Cancer Risk Screening Model
NCT ID:
NCT05634798
Condition:
Endometrial Neoplasms
Conditions: Official terms:
Endometrial Neoplasms
Study type:
Observational [Patient Registry]
Overall status:
Unknown status
Study design:
Time perspective:
Prospective
Intervention:
Intervention type:
Other
Intervention name:
no intervention
Description:
There is no intervention in this study.
Summary:
The goal of this observational study is to test the efficiency of our endometrial cancer
risk screening calculator, and improve the endometrial cancer risk screening model to
form a stable and reliable non-invasive auxiliary diagnostic tool with high sensitivity
and specificity in healthy women.The main question it aims to answer is:
·the efficiency of our endometrial cancer risk screening calculator Participants will be
collected demographic information, as well as ultrasound, blood routine test and other
test results, which will be entered into the endometrial cancer risk screening calculator
to obtain high-risk or low-risk prediction results.
Criteria for eligibility:
Study pop:
The subjects were women of childbearing age, perimenopause and postmenopausal who had
undergone physical examination in Peking Union Medical College Hospital or were recruited
by patients from gynecological clinics.
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
1. Age: 18-70;
2. The annual update of questionnaire information required by the calculator can be
completed, and the gynecological examination, gynecological B-ultrasound and blood
test can be evaluated once a year, and the follow-up can be at least 1 year; The
patient or family members can understand the research scheme and are willing to
participate in the study, and provide e-book informed consent.
Exclusion Criteria:
1. Endometrial cancer or precancerous lesions have been diagnosed;
2. Previous or current malignant tumor, currently receiving radiotherapy and
chemotherapy, endocrine, targeted and immunotherapy;
3. History of endometrial resection or total hysterectomy;
4. Pregnant or lactating women;
5. The patient or family member could not understand the conditions and objectives of
this study.
Gender:
Female
Minimum age:
18 Years
Maximum age:
70 Years
Healthy volunteers:
Accepts Healthy Volunteers
Locations:
Facility:
Name:
Peking Union Medical College Hospital
Address:
City:
Beijing
Zip:
100730
Country:
China
Status:
Recruiting
Contact:
Last name:
Shu Wang, associated professor
Phone:
+86-136-7124-6680
Email:
wangshu219@hotmail.com
Start date:
December 1, 2022
Completion date:
December 1, 2023
Lead sponsor:
Agency:
Peking Union Medical College Hospital
Agency class:
Other
Source:
Peking Union Medical College Hospital
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05634798
